What Is Barrett's Esophagus? PDF Print E-mail
Wednesday, 07 October 2009 12:07
taken from http://www.flickr.com/photos/stewiedewie/114310672/ via creative commonsBarrett's esophagus is a precancerous condition in which the lining of the esophagus is replaced by abnormal cells, with the esophagus being that tube which connects the throat to the stomach.

The esophagus is connected to the stomach by a muscular ring called the esophageal sphincter. This muscle performs two major functions. It opens to allow food to pass into the stomach, and it also closes to keep the contents of the stomach from splashing back up into the esophagus.

If this sphincter weakens or relaxes, the contents of the stomach splash back up into the esophagus. This splashing is known as gastroesophageal reflux disease, or GERD.

The lining of the esophagus is not made for this kind of abuse. After being exposed to stomach acid over a long period of time, the lining of the esophagus changes. This change in the lining of the lower esophagus is called Barrett's esophagus.

GERD is the major cause of Barrett's esophagus. Esophagitis, or chronic inflammation of the esophagus, can also lead to Barrett's esophagus. One-third of all people with Scleroderma, a skin disorder, develop Barrett's esophagus. For some unknown reason, Barrett's esophagus occurs three times more often in males than in females.

GERD can be caused by a weak esophageal sphincter that is present at birth or develops later in life. A hiatal hernia can also cause GERD. Hiatal hernia is a condition in which the stomach pushes up into the diaphragm muscle. When this happens, the esophageal sphincter does not work properly. As a result, the fluid can easily leak back into the esophagus.

There are several factors which make GERD worse including drinking alcohol or caffeine, drinking carbonated beverages or fruit juice, and eating fatty or spicy foods. Despite the availability of some common medical and surgical treatments for GERD, unfortunately, there is nothing that can prevent the cells of Barrett's esophagus from changing into cancer. However, it is important to treat the GERD to prevent further damage.

Your doctor may order regular esophagoscopy exams to check for cancer. Any new or worsening symptoms should be reported to your doctor as well.

Read the full article on Barrett's Esophagus, by Amanda Wattson here, and for more information on Barrett's via the NDDIC via this link.
 
More articles :

» Mouth Exercises For Scleroderma

The loss of facial mobility may restrict the ability to chew foods and perform adequate moth hygiene. Below is some advice on maintaining facial mobility through exercise.INSTRUCTIONS:Do exercises in front of a mirror. Massage (firm touch) the...

» Testing New Drugs for Early Diffuse Systemic Sclerosis

For patients with the connective tissue disease known as Systemic Sclerosis or – there are few reliable drug treatments. There has been emerging interest in the potential of a class of drugs called (TKI) to ameliorate a major feature of the...

» Management

Our Management Team or Executive Committee is presently responsible for the daily operations of the Scleroderma Care Foundation, realizing its vision, and similarly ensuring its growth and future success. Adelwyn Holder, Co-Founder &...

» FDA Approves New Lupus Drug

The FDA has approved (Benlysta) for reducing disease activity in (SLE), making it the first new lupus drug in more than 50 years. Belimumab is a monoclonal antibody targeting the B-lymphocyte stimulator protein, called BLyS. It was co-developed by...

» Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?

Jo N. Fleming, Richard A. Nash, D. O. McLeod, David F. Fiorentino, Howard M. Shulman, M. Kari Connolly, Jerry A. Molitor, GretchenHenstorf, Robert Lafyatis, David K. Pritchard, Lawrence D. Adams, Daniel E. Furst, Stephen M....

» Scleroderma Foundation Medical Advisory Board Offers Consensus On Gleevec

® (imatinib mesylate, Novartis) is approved in the United States for the treatment of certain forms leukemias and solid tumors. The recent discovery that Gleevec® inhibits important cellular enzymes that control fibrosis led to studies to evaluate...